Biotech Values

[semi_infinite]

Finally read the whole article and it is well done and summarizes the situation well. It is all about Intuitive's Da Vinci since that forms all of the data used in the JAMA papers. For well utilized systems such as those in the Stanford area (Sutter Health, El Camino hospital for example), the cost savings of switching to lap-robotics from Da Vinci robotics would be ~$400K annually on instruments alone on top of time savings. That's one heck of a gradient. Senhance is the only commercially available lap robot (that is capable of using existing lap instruments and being able to reposition patient easily during surgery) for now.